Viral Hemorrhagic Fevers
Istanbul, 27-28 June 2008
Coordinators:
Murat Akova, MD (ESCMID Education Officer)
Onder Ergonul MD, MPH
Giorgio Palu, MD
Organizing Committee:
Giuseppe Cornaglia
Murat Akova
Onder Ergonul
Giorgio Palu, Italian Society for Virology
Haluk Eraksoy, Turkish Society of Clinical Microbiology and Infectious Diseases (Klimik Society)
Objectives:
- Learning from global experiences of different groups of viral hemorrhagic fevers
- Define priorities for clinical and public health practices and to define research areas.
Target audience: basic research scientists, virologists, microbiologists, clinicians, clinicians, public health officers
Conference venue: Istanbul
Supporting organisations:
- European Society of Clinical Microbiology and Infectious Diseases
- Turkish Society of Clinical Microbiology and Infectious Diseases (Klimik Society)
- Italian Society for Virology
Date:27-28 June 2008
Optional Social program (to be charged): 29 June 2008, Sunday: 10.00-15.00
Walking and sailing tour in medical history of Istanbul: A guidance booklet will be provided.
Tuition fee: 300 Euro, 250 Euro for members
The Program
Thursday, 26 June 2008
Arrival to the city and to the hotels
Friday, 27 June 2008
8.30-9.30: Sesssion 1. Introduction and Historical Perspectives: overview.
Onder Ergonul and Mike Bray
9.30-10.00: Coffee break
10.00-11.30: Session 2. Epidemiological and Clinical Features
Lassa Fever: Dan Bausch
Bunyaviral HF, Crimean Congo Hemorrhagic Fever: Nurcan Baykam
Hemorrhagic Fever with Renal Syndrome: Tatjana Avsic Zupanc
Flaviviral HF & Dengue Fever, Toscany virus: Loredana Nicoletti
Rift Valley Fever: Janusz Pawoski
11.30-12.30: Etiologic agents
Molecular Biology:Roger Hewson
12.30-13.30: Lunch
13.30-14.30: Session 3.Epidemiology and ecology
Ecology of Tick-Borne Disease and the Role of Climate: Sarah Randolph
The use of spatial maps: Climate: Agustin Estrada Pena
Mathematical models: Ben Cooper
14.30-15.30: Session 4. The Vectors and the reservoir
The role of vectors: Aysen Gargılı
Ticks and infection among animals: Zati Vatansever
Animal models and the potential problems: Sina Bavari
15.30: 16.00: Coffee break
16.00-18.00: Session 5. CCHF roundtable discussion: An Euroasian Perspective.
Onder Ergonul
Anna Papa
Sadegh Chinikar
Kenan Midilli
Zulal Ozkurt
Nazif Elaldi
19.30:Dinner cruise on the Bosphorus
Saturday, 28 June 2008
9.00-10.30: Session 6. Pathogenesis
Comparison of Ebola and CCHF: Mike Bray
Pathogenesis of VHF: Thomas Geisbert
Flaviviral HF: Pathogenesis:
Pathogenesis of sepsis: Thierry Calandra
10.30-11.00: Coffee Break
11.30-12.30: Session 7. Laboratory Diagnosis: Herve Zeller
12.30-13.30: Lunch
13.30-14.30: Session 8.Current Treatment and alternatives:
Clinical course and the Treatment:Onder Ergonul
Perspectives for the development of potent antivirals against viruses causing haemorrhagic diseases: Johan Neyts
Emerging viruses and potential antivirals: Remi Charrel
14.30-15.00: Coffee Break
15.00-16.30: Session 9.Prevention and Control
Health care workers and nosocomial VHFs: Arnaud Tarantola & Masoud Mardani
Vaccination experience: Delia Enria (Argentina)
A new veterinary vaccine against Rift Valley Virus: Michele Bouloy
International Surveillance and Control of VHF Outbreaks: Pierre Formenty
Vector Transmission Interruption Strategies: Mark Klempner
16.30-16.45: Coffee Break
16.45-17.00: Evaluation
Faculty members
Dan Bausch (USA)
Sina Bavari (USA)
Tatjana-Avsic Lupanc (SL)
Michele Bouloy (FR)
Remi Charrel (FR)
Sadegh Chinikar (IR)
Ben Cooper (UK)
Guiseppe Cornaglia (IT)
Delia Enria (Argentina)
Onder Ergonul (TR)
Agustin Estrada-Pena (S)
Ayşen Gargılı (TR)
Thomas Geisbert (USA)
Roger Hewson (UK)
Mark Klempner (USA)
Masoud Mardani (IR)
Kenan Midilli (TR)
Johan Neyts (BE)
Loredana Nicoletti (IT)
Giorgio Palu (IT)
Janusz Pawoski (South Africa)
Sarah Randolph (UK)
Zati Vatansever (TR)
Chris Whitehouse (USA)
Herve Zeller (FR)
1